Stemline Therapeutics Inc (NASDAQ:STML)

During the Trading Day
11.82 +0.05 / +0.42%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.82 0.00 / 0.00%
 
Volume: 1.6K
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale3/19/201517,307$16.43$284.4K-27.26%
Bergstein Ivan
Chief Executive Officer
Sale11/26/201411,974$14.40$172.4K-20.42%
Hoberman Kenneth
Chief Operating Officer
Buy3/19/201527,105$4.09$110.9K-27.26%
Gionco David G
Chief Accounting Officer
Sale1/20/20153,311$14.22$47.1K-17.52%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K-16.41%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K-16.41%
Bentsur Ronald
Director
Sale3/18/20151,388$16.12$22.4K-26.11%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K-16.41%
Bentsur Ronald
Director
Buy3/18/20155,421$4.09$22.2K-26.11%
Bergstein Ivan
Chief Executive Officer
Buy9/03/20142,000$11.05$22.1K+7.78%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account